- Filed
- May 6, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 23, 2026 | 2.51B sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 2.49B sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 2.46B sh |
| Capex | Q1 2026 · Mar 31, 2026 | $268M |
| Capex | Q1 2026 · Mar 31, 2025 | $251M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$208M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $553M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $3.26B |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $4.57B |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $32.58B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $35.92B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $16.12B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $12.5B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $64.13B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $62.92B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $11.74B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $13.21B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $97.84B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $100.09B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$1.17 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.18 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$1.17 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.18 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $2.48B |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $2.19B |
| Net Income | Q1 2026 · Mar 31, 2026 | −$2.92B |
| Net Income | Q1 2026 · Mar 31, 2025 | −$453M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$2.47B |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$37M |
| Revenue | Q1 2026 · Mar 31, 2026 | $8.89B |
| Revenue | Q1 2026 · Mar 31, 2025 | $8.98B |